Grace Therapeutics (GRCE) Other Working Capital Changes (2022 - 2023)
Grace Therapeutics (GRCE) posted Other Working Capital Changes of $50000.0 for Q1 2021, up 5100.0% sequentially from -$1000.0 in Q4 2020, and down 77.78% YoY from $225000.0 in Q1 2020.
Grace Therapeutics (GRCE) Other Working Capital Changes (2022 - 2023) Analysis & Trends
Grace Therapeutics has reported Other Working Capital Changes for 3 years, with the latest figure at $50000.0 in Q1 2021.
- Quarterly Other Working Capital Changes fell 100.71% year-over-year to -$10000.0 in Q3 2023, while the trailing twelve-month figure through Jun 2024 was -$10000.0 (down 100.79% YoY) and the FY2024 annual result came in at -$23000.0, changed N/A from the prior year.
- Other Working Capital Changes grew to -$10000.0 in Q3 2023 per GRCE's latest filing, from -$13000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $1.4 million in Q3 2022 and troughed at -$1.3 million in Q2 2022.
- A 3-year average of $48000.0 and a median of -$1000.0 in 2020 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2020 and 2021: Other Working Capital Changes soared 90.0% in 2020, then sank 77.78% in 2021.
- Over 2 years, Other Working Capital Changes stood at -$137000.0 in 2022, then soared by 92.7% to -$10000.0 in 2023.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$10000.0, -$13000.0, and -$137000.0 for Q3 2023, Q2 2023, and Q4 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.84 Bn | 131.99 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.48 Bn | 78.49 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn |
| 4 | Moderna | 60.15 Bn | 55.01 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.22 Bn | 37.12 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.54 Bn | 10.14 Bn | 668.28 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.22 Bn | 26.38 Bn | - |
| 10 | Grace Therapeutics | 37.99 Mn | 37.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -10,000.00 |
| Sep 30, 2023 | -10,000.00 |
| Sep 30, 2023 | -10,000.00 |
| Jun 30, 2023 | -13,000.00 |
| Jun 30, 2023 | -13,000.00 |
| Jun 30, 2023 | -13,000.00 |
| Dec 31, 2022 | -137,000.00 |
| Dec 31, 2022 | -137,000.00 |
| Dec 31, 2022 | -137,000.00 |
| Sep 30, 2022 | 1.41 Mn |
| Sep 30, 2022 | 1.41 Mn |
| Sep 30, 2022 | 1.41 Mn |
| Jun 30, 2022 | -1.27 Mn |
| Jun 30, 2022 | -1.27 Mn |
| Jun 30, 2022 | -1.27 Mn |